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The ubiquitin proteasome system (UPS) comprises hun-
dreds of different conjugation/deconjugation enzymes and
multiple receptors that recognize ubiquitylated proteins. A
formidable challenge to deciphering the biology of ubiquitin
is to map the networks of substrates and ligands for com-
ponents of the UPS. Several different receptors guide ubiq-
uitylated substrates to the proteasome, and neither the
basis for specificity nor the relative contribution of each
pathway is known. To address how broad of a role the
ubiquitin receptor Rpn10 (S5a) plays in turnover of protea-
some substrates, we implemented a method to perform
quantitative analysis of ubiquitin conjugates affinity-purified
from experimentally perturbed and reference cultures of
Saccharomyces cerevisiae that were differentially labeled
with 14N and 15N isotopes. Shotgun mass spectrometry
coupled with relative quantification using metabolic label-
ing and statistical analysis based on q values revealed ubiq-
uitylated proteins that increased or decreased in level in
response to a particular treatment. We first identified over
225 candidate UPS substrates that accumulated as ubiq-
uitin conjugates upon proteasome inhibition. To determine
which of these proteins were influenced by Rpn10, we eval-
uated the ubiquitin conjugate proteomes in cells lacking
either the entire Rpn10 (rpn10) (or only its UIM (ubiquitin-
interacting motif) polyubiquitin-binding domain (uim)).
Twenty-seven percent of the UPS substrates accumulated
as ubiquitylated species in rpn10 cells, whereas only one-
fifth as many accumulated in uim cells. These findings
underscore a broad role for Rpn10 in turnover of ubiquity-
lated substrates but a relatively modest role for its ubiq-
uitin-binding UIM domain. This approach illustrates the fea-
sibility of systems-level quantitative analysis to map
enzyme-substrate networks in the UPS. Molecular & Cel-
lular Proteomics 6:1885–1895, 2007.
The classical function of ubiquitylation is to direct sub-
strates for proteolysis via the ubiquitin proteasome system
(UPS).1 Recognition of proteasome substrates is specifically
mediated by several receptor proteins (1). In yeast, there are
at least five potential receptors (Ddi1, Dsk2, Rad23, Rpn10,
and Rpt5) plus a set of Cdc48-based complexes, including
the Cdc48-Npl4-Ufd1 heterotrimer, that may possess recep-
tor function (2–7). This diversity of postubiquitylation targeting
pathways is mystifying. Currently it is not known which subset
of proteasome substrates is targeted by a given receptor or
what features govern the allocation of substrates to a partic-
ular receptor pathway.
The yeast Rpn10 protein is a stoichiometric component of
the 26 S proteasome and was the first protein found to bind
polyubiquitin chains (8). Its amino-terminal domain consists of
a conserved von Willebrand A (VWA) motif that docks Rpn10
to the proteasome. Recruitment of ubiquitin chains to Rpn10
is mediated by the 20-amino acid ubiquitin-interacting motif
(UIM) domain located near its carboxyl terminus (9). S5a pro-
tein, the human Rpn10 ortholog, contains a second UIM do-
main that is thought to mediate the recruitment of other re-
ceptor proteins (10). The general impact of Rpn10 on the
turnover of proteasome substrates is not known. Given that
budding yeast rpn10 mutants are viable (11, 12), Rpn10 may
be required for the turnover of only a small subset of ubiqui-
tylated proteins, or Rpn10 may target a large number of
substrates that, in its absence, are targeted by other protea-
somal receptors (e.g. Rad23 or Dsk2). Even less well under-
stood is the contribution of the two domains of Rpn10 to
substrate turnover. Complete deletion of RPN10 (i.e. rpn10)
stabilizes the cell cycle regulator Sic1 and the transcription
factor Gcn4. Paradoxically removal of the UIM domain by
itself (i.e. uim) has no discernable effect on either of these
substrates (5)2 suggesting that Rpn10 function may rely solely
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on an uncharacterized biochemical activity associated with its
VWA domain.
To understand fully the biological roles of protein ubiquity-
lation and the functions of individual components of the UPS
such as Rpn10, it will be necessary to identify UPS substrates
on a proteome-wide scale. Several studies have started to
address this challenge using mass spectrometry to analyze
the ubiquitin proteome (13–18). Although these seminal stud-
ies illustrate that shotgun mass spectrometry is a powerful
tool that can provide a systems-level view of the ubiquitin
proteome, it is clear that application of this technology to the
ubiquitin system remains in an embryonic state. For example,
no proteomics study has yet succeeded in identifying even
one of the 11 yeast G1 and mitotic cyclins that are well known
substrates of the UPS. Indeed many ubiquitin conjugates
identified in proteomics experiments might be stably accumu-
lating species that are not substrates of the UPS. To obtain
more focused information from shotgun mass spectrometry
experiments, we and others have previously applied subtrac-
tive approaches to identify conjugates that accumulate in
rpn10 (15) and in npl4ts but not ubc7 mutants (18). Al-
though this strategy allowed the identification of several ubiq-
uitylated proteins, by its nature the subtractive approach ex-
cludes substrates whose accumulation is only partially
dependent upon a given factor. This is a major concern given
the redundancy of many UPS pathways (5, 19). No fewer than
six ubiquitin ligases (Mdm2, Pirh2, p300, PARC, Cul7, and
Cop1) have been implicated in p53 regulation (20–22), and at
least three different ubiquitin chain receptors contribute to
turnover of ubiquitylated Sic1 (5). Clearly a method that allows
for more subtle quantitative comparisons is needed.
In this study, we adapted stable isotope labeling techniques
that have been used previously to address a variety of bio-
logical problems to perform relative quantitative analysis of
polyubiquitylated proteins in two distinct cell cultures. By
applying a statistical approach based on p and q values, we
were able to identify ubiquitylated proteins whose levels are
altered in response to a specific perturbation (chemical or
genetic). After validating the approach, we used this method
to identify putative substrates of the proteasome and to de-
termine the contribution of the Rpn10 proteasome receptor
pathway in the targeting of UPS substrates. We further dis-
sected the function of Rpn10 by assessing the role of its UIM
domain.
MATERIALS AND METHODS
Strains—All Saccharomyces cerevisiae strains used in this study
are listed in Supplemental Table 1. RJD2997, which constitutively
expresses His6-ubiquitin, was described previously (23). PDR5 was
deleted to increase sensitivity to the proteasome inhibitor MG132
(24). To obtain a prototrophic strain for labeling with heavy nitrogen,
we reverted auxotrophic markers by homologous recombination. The
following genes were PCR-amplified using the indicated pair of prim-
ers: ADE2 (5-TATTAGTGAGAAGCCGAGA, 5-GATCTTATGTAT-
GAAATTCTT), LEU2 (5-TGGTTGTTTGGCCGAGCGG, 5-TCGAC-
TACGTCGTTAAGGCC), and URA3 (5-TCTTAACCCAACTGCACAG,
5-GTGAGTTTAGTATACATGC). The PCR-amplified fragments were
purified and transformed into W303 cells, and revertants were iden-
tified by applying the corresponding selection. RJD3313 and -3314
were obtained by successive crosses until all the markers were re-
verted. Both rpn10 and uim (5) were crossed with RJD3314 to
obtain RJD3315 and RJD3318, respectively.
Isotopic Labeling and Two-step Purification—Cells were grown in
YNB-D (0.17% yeast nitrogen base without amino acids and ammo-
nium sulfate, 5% dextrose, 20 g/ml ampicillin) supplemented with
0.5% ammonium sulfate (14N) at 25 °C to an A600 between 0.5 and 1,
washed three times with YNB-D only, and then diluted to an A600 of
0.008 in 2 liters of YNB-D with 0.5% 14N- or 15N-labeled (98%,
Cambridge Isotope Laboratories) ammonium sulfate. The two differ-
ent isotopically labeled cell cultures were grown in parallel at 25 °C to
an A600 of 1 (seven generations), and a drug treatment was applied for
30 min where indicated. Each isotopically labeled culture was then
harvested by centrifugation and resuspended in 400 ml of ice-cold
TBS. The A600 was carefully measured, and equal amounts of cells for
each isotope variant were mixed together, centrifuged, resuspended
in 200 ml of ice-cold TBS with 1 mM 1,10-phenanthroline and 10 mM
iodoacetamide, recentrifuged, and snap frozen in liquid nitrogen. The
two-step purification and tryptic digestion of ubiquitin conjugates was
carried out as described previously (23) with the following minor
changes: cells were broken in 40 ml of lysis buffer after which 1.8 mg
each of recombinant GST-Rad23 and GST-Dsk2 coupled to Sepha-
rose were used for the first step and 100 l of nickel magnetic bead
slurry (Promega) were used for the second. Typically only one-half of
the sample was analyzed in a single LCQ analysis (corresponding to
1 liter of each labeled cell sample), whereas with the LTQ, material
corresponding to 500 ml of each labeled culture was analyzed. An
aliquot (10 l) of cleared total cell extract was collected after the first
centrifugation, precipitated (25), and resuspended in UB buffer (8 M
urea, 100 mM NaH2PO4, 10 mM Tris-HCl, pH 8.0). 5 g of protein were
subjected to tryptic digest, mass spectrometry, and quantitative anal-
ysis to calculate the average ratio of isotopically labeled proteins in
the total cell extract (median of 14N/15N ratio values).
Mass Spectrometry Analysis, Computation, and Statistical Analy-
sis—The proteolytically digested proteins analyzed in Fig. 1 were
evaluated by multidimensional chromatography coupled in line to
ESI-MS using an LCQ-Deca mass spectrometer (ThermoFisher) as
described previously (15, 26). Samples in Figs. 3–5 were analyzed
with an LTQ ion trap (ThermoFisher) using a modified protocol (sup-
plemental information). Sequest and DTASelect (27, 28) were used to
analyze the mass spectrometry profiles using two sets of parameters
for 14N and 15N searches (supplemental information). Proteins iden-
tified by at least two peptides (Supplemental Table 2) were retained
for the quantitative analysis, and peptides (14N and 15N) were sepa-
rately analyzed with RelEx (versions 0.91 and 0.92 (29)) using the
following parameters: (i) width option was 75 scans with LCQ and
25 scans with LTQ data; (ii) for purified material, ratio correction was
applied using the (median ratio)1 value derived from total cell extract;
(iii) regression filter was applied (minimum correlation, 0.7 at 1 and 0.4
at 10); and (iv) signal to noise filter was applied (minimum of 3 for LCQ
and 5 for LTQ data). The files from the two separate analyses (14N and
15N) were merged and sorted using RelEx (Supplemental Table 3).
For the purposes of statistical analysis, the 14N/15N ratios were
analyzed on a base 2 logarithmic scale. Due to a lack of biological
interpretability, the following ORFs were removed prior to statistical
analysis: YIL148W, YLR167W, YLL039C, and YKR094C (ubiquitin
genes); YMR276W and YEL037C (Dsk2 and Rad23, respectively,
contaminants from the purification); YML042W, YBR195C, and
YGL178W. The background variability (2) of log ratios was estimated
from the data observed in the reference experiment (supplemental
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information), which specified a null distribution for log ratios, i.e. a
normal distribution with mean 0 and variance 2/n where n is the
peptide number. For each ORF quantified in RelEx, the observed log
ratio and peptide number were compared with this null distribution to
obtain a two-sided p value.
p value (log ratio) pZ n
 log (ratio)/ref) where Z is N0,1 (Eq. 1)
To permit the control of the false discovery rate (FDR) (30) in subse-
quent lists of putative proteasome substrates, we computed adjusted
p values, also known as “q values” (31),
q value (p(i))pi0m/i (Eq. 2)
where p(i) is the ith order statistic of the observed p values, 0 is the
(estimated) proportion of unresponsive proteins, and m is the number
of proteins quantified. To calculate the recovery rate associated with
a q value cutoff equal to q(i), note that, on average, i 	 q(i) of the
i“discoveries” are false and conversely that i 	 (1  q(i)) of the i
discoveries are true. Overall m	 (1 0) ORFs are thought to be truly
responsive; therefore we can estimate the fraction of these that have
been recovered in any given list of putative proteasome substrates.
Recovery rate (qi) i 1 qi/m 10 (Eq. 3)
All statistical analysis was performed using the software environment
R (The R Project for Statistical Computing) and the q value package.3
Analysis scripts are provided in the supplemental information. Fre-
quency distribution, Deming regression, and Fisher’s test analyses
were performed with Prism 4.0 (GraphPad), and list analysis was
performed with Excel (Microsoft) using filter functions.
One-step Purification/Immunoblot Analysis of Ubiquitin Conju-
gates—For IMAC purification of His8-ubiquitin, cells transformed with
RDB1851 (15), a URA3-based plasmid constitutively expressing His8-
ubiquitin, were grown in 100 ml of SD-URA medium (0.67% yeast
nitrogen base, 5% dextrose) at 30 °C to an A600 of 1 and then treated
for 30 min with MG132 (20 M) or DMSO only (160 l). Samples were
prepared as described previously (15) with the following modifica-
tions: trichloroacetic acid was added to a 10% final concentration to
the cell cultures, and 50 l of nickel magnetic bead slurry (Promega)
were used. TAP tagged proteins were detected using the anti-calm-
odulin-binding peptide antibody (Upstate; Fig. 2) or the anti-TAP
polyclonal antibody (Open Biosystems; Fig. 4), and Cdc28 was de-
tected for loading control in total cell extract using the PSTAIRE
antibody (Santa Cruz Biotechnology).
RESULTS
Quantitative Analysis of Ubiquitin Proteome—The first
question we sought to address was to determine which pro-
teins in the ubiquitin proteome are likely to be true UPS
substrates as opposed to proteins regulated by ubiquitylation
in a non-proteolytic manner or contaminants. Identification of
true substrates of the UPS is an important issue because
among all the ubiquitylated proteins identified in prior pro-
teomics studies only a handful (e.g. Sic1 and Gcn4) corre-
spond to known UPS substrates, and many of the reported
proteins are relatively stable. To address this question, we
sought a method that would enable us to perform relative
quantification against an internal standard of the hundreds of
ubiquitylated proteins that are obtained upon affinity purifica-
tion of ubiquitin conjugates. The general idea was to identify
those ubiquitylated proteins that showed elevated accumula-
tion, relative to an internal standard, when the proteolytic
activity of the proteasome was chemically inhibited. Multiple
methods have been developed to enable quantification (e.g.
ICAT, SILAC (stable isotope labeling by amino acids in cell
culture), iTRAQ (isobaric tags for relative and absolute quan-
titation), 15N and 18O isotopic labeling, and label-free peak
comparison (32)). To exclude variations introduced during the
preparation of the samples to be compared (our approach
involved a two-step biochemical purification), we opted for
biosynthetic labeling with 15N. Yeast cells expressing His6-
tagged ubiquitin and grown in medium provided with normal
(14N) nitrogen were incubated with the proteasome inhibitor
MG132, whereas the same cells grown in medium formulated
with “heavy” (15N) nitrogen were mock-treated (DMSO). The
two cultures were then mixed together and lysed, and ex-
tracts were subjected to sequential affinity purifications on
Rad23-Dsk2 resin and Ni2
 magnetic beads as described
previously (23). The resulting pool of ubiquitylated proteins
was digested with trypsin and subjected to shotgun mass
spectrometry (MudPIT) (33) followed by quantitative analysis
using RelEx (29). We reasoned that ubiquitylated proteins
normally targeted for proteolysis would accumulate in the
cells treated with MG132 because they could no longer be
degraded. Hence the relative amount of any given 14N-labeled
peptide derived from one of these proteins compared with its
15N-labeled isotopomer (i.e. the 14N/15N ratio) should be
greater than 1 (Fig. 1A). In contrast, proteins that are not
targeted for proteasomal degradation, including proteins con-
jugated to Lys-63 polyubiquitin chains or contaminating (i.e.
non-ubiquitylated) material from the purification, should gen-
erate ratio values close to 1 (Fig. 1A).
To identify proteasome substrates, we had to articulate
exactly what constituted compelling evidence that a protein is
truly enriched or depleted in the MG132-treated cells. An
absolute threshold, such as requiring an observed 2-fold in-
crease or decrease, suffers from two disadvantages. 1) It
does not normalize the observed ratio by comparison with the
background variability arising purely from biological and ex-
perimental noise, and 2) it does not acknowledge the in-
creased confidence that arises when a protein is represented
by, for example, 10 distinct peptides as opposed to just three.
To avoid these pitfalls, we opted for a statistical approach.
The quantitative data taken for each protein is the average log
ratio of all sequenced peptides derived from it using a base 2
logarithm. We obtained a “null distribution” of log ratios de-
fined as the distribution of log ratios observed in a reference
experiment in which both the 14N- and 15N-labeled cells re-
ceived the same mock treatment (Fig. 1B, top panel). Data
were obtained for peptides representing 159 different proteins
(all quantitative data are provided in Supplemental Table 3).
Based on the assumption that log ratios in a null distribution3 A. Dabney and J. D. Story, personal communication.
UPS Proteome and Rpn10 Delivery Pathway
Molecular & Cellular Proteomics 6.11 1887
 at California Institute of Technology on Novem
ber 30, 2007 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
will be centered at 0, it follows that the null distribution for a
protein represented by averaging log ratios from n peptides
will also be centered at 0 with variance 2/n. Our distributional
assumptions (normal distribution, centered at 0) and the im-
plied relationship between variance and peptide number
(2/n) are consistent with the data observed in the reference
experiment (Fig. 1, B and C, top panels). Using an averaging
approach that accounted for differences in peptide number
(supplemental information), we estimated the variance (2) of
the null distribution to be 0.24.
To assess the impact of proteasome inhibition on the com-
position of the ubiquitin proteome, we treated cells labeled
with 14N with the proteasome inhibitor MG132 for 30 min,
whereas DMSO was added to 15N control cells. Log ratios
were obtained for 140 proteins, and as expected, the ob-
served distribution was shifted toward positive values and
was generally more spread out, suggesting that the treatment
induced meaningful differences in protein abundance with
evidence for a higher prevalence of enrichment (ratios 1 or
positive log ratios) than depletion (Fig. 1B, middle panel;
examples of ratio calculation for two 14N-enriched peptides
are shown in Supplemental Fig. 1). To evaluate the reproduc-
ibility of the ratio measurements and ensure that the enrich-
ment of proteins in the 14N sample was due to the proteasome
inhibitor, we performed a “reciprocal” experiment in which
MG132 was added to the 15N-labeled cells and DMSO was
added to 14N cells. The observed data distribution was as
expected with a general shift to negative log ratio values and
a much greater range of values relative to the reference ex-
periment (Fig. 1B, bottom panel). Further evidence of repro-
ducibility is found in the high correlation between the peptide
numbers of proteins appearing in both the original MG132
FIG. 1. Quantitative analysis of the ubiquitin proteome and proteasome substrates. A, schematic representation of the isotopic labeling
approach. Two cell populations were separately grown in medium containing 14N (blue) or the stable isotope 15N (green) for several generations
until all proteins were uniformly labeled. The proteasome inhibitor MG132 was applied to cells grown in 14N, whereas 15N-labeled cells were
treated with DMSO, the solvent used to dissolve MG132. After ratiometric quantitative mass spectrometry analysis, each identified protein was
assessed for its relative enrichment. B, frequency distributions of log ratios in the quantitative analyses of the ubiquitin proteome. The top panel
represents the reference experiment performed using DMSO in both 14N and 15N cells. The middle panel corresponds to MG132 analysis in
which 14N cells were treated with MG132, and the lower panel displays the MG132 reciprocal experiment in which 15N cells were treated. The
bell-shaped distribution obtained in the reference experiment is depicted as a dotted line in the three panels. C, scatter plots of the log ratios
and the associated peptide numbers. The analyses are ordered as in B. Points that lie outside the dotted lines deviate from the normal
distribution with a p value of 0.1 or less. A small number of extreme log ratios are beyond the scale of the horizontal axis and are therefore not
depicted here. Note that several proteins were quantified using only one peptide, whereas protein identifications strictly required at least two
peptides. D, recovery rate (proportion of truly responsive ORFs that are identified) as a function of FDR. The selected q value cutoff is depicted
in gray. Very similar results were obtained in the reciprocal analysis (data not shown).
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analysis and the reciprocal experiment (Supplemental Fig.
2A). Moreover a Deming regression analysis of the log ratios
exhibited by the proteins identified in the two experiments
yielded a fit that is compatible with the ideal x  y relationship
predicted by theory (Supplemental Fig. 2B). Taken together,
this evidence confirms that the MG132 treatment similarly
affected ubiquitylation levels of proteins analyzed in both
experiments.
For each protein, we obtained a two-sided p value by using
the null distribution to compute the probability that its log ratio
in the MG132 experiment could arise by stochastic fluctuation
(Supplemental Table 4). With this approach, one expects that
ubiquitylated proteins that are insensitive to MG132 treatment
will exhibit p values close to 1, whereas ubiquitylated proteins
that exhibit robust accumulation upon MG132 treatment will
exhibit p values close to 0 (in Fig. 1C the dotted lines indicate
log ratios that have an associated p value of 0.1). Because we
computed and interpreted p values for hundreds of proteins
simultaneously, it was desirable to adjust them such that by
thresholding the adjusted p values at some fixed level we
could specify an appropriate error rate for the entire collection
of p values. We used a method of p value adjustment that
provides control of the FDR (30) defined as the expected
proportion of discoveries (i.e. proteins claimed to be enriched
or depleted due to treatment) that are actually false discov-
eries (i.e. proteins unaffected by treatment). These adjusted p
values are often called q values (31), and a useful and inter-
pretable by-product of the q value computation is an estimate
of the proportion of studied proteins that are truly unrespon-
sive to the experimental perturbation, often denoted 0. Fur-
ther computation also allowed us to estimate the “recovery
rate” associated with each potential q value cutoff defined as
the proportion of proteins that respond to the perturbation
that would be discovered. Supplemental Table 4 contains p
and q values, 0, and recovery rates for all experiments, and
Fig. 1D represents the results for the MG132-analysis. We
chose to set the FDR at the level of 5%, which produces a
high quality list of candidates (on average, only 5% will be
false “hits”) while also promising a very high recovery rate
(estimated to be 80% in both MG132 analysis and recipro-
cal experiments). To identify those proteins that are the best
candidates for proteasome substrates, we then narrowed our
focus to proteins enriched in cells treated with MG132 (Sup-
plemental Table 5).
Validation of UPS Substrates—To evaluate the legitimacy of
our approach, we sought to validate candidate proteasome
substrates using a completely orthogonal method. Yeast cells
expressing His8-ubiquitin and carrying a TAP tagged allele at
the endogenous locus of each tested candidate gene were
treated with or without MG132, lysed, and subjected to IMAC
followed by immunoblotting for the TAP tag (Fig. 2A). Control
experiments were done in parallel with an untagged strain and
in the absence of His8-ubiquitin expression to evaluate spec-
ificity. Upon addition of MG132, increased ubiquitylation was
observed for 17 of the 18 tested candidates (Fig. 2B). Notably
several proteins with q values close to the 0.05 threshold (e.g.
Rps8A) were shown to accumulate as ubiquitylated species
after proteasome inhibition. These data provide strong evi-
dence that the list of proteins derived by our approach is
highly enriched for proteasome substrates.
The UPS Proteome—During the course of this study, we
acquired an LTQ linear ion trap mass spectrometer that en-
abled us to obtain quantitative information on more than 500
proteins in a single 10-h analysis (Fig. 3A), thereby revealing
225 proteins that were specifically enriched in MG132-treated
cells (using the same approach as in Fig. 1; Supplemental
Table 6). Thus, 3–4% of all proteins encoded in the yeast
genome detectably accumulated as ubiquitylated species
when the proteasome was inhibited. Using this more substan-
tial collection of candidate UPS substrates, we performed in
silico analyses to determine the functions, localization, and
expression level of proteins targeted to the UPS. Candidate
UPS substrates were distributed across many different func-
tional classes (Fig. 3B) with proteins involved in small mole-
cule metabolism accounting for the biggest fraction (24%).
Notably we also identified many cell cycle control proteins
(10%), including Cdc5, Cdc20, Clb2, Cln1, Cln2, and Far1,
which are known substrates of the proteasome (34–38). Com-
FIG. 2. Analysis of candidate substrates of the proteasome. A,
schematic representation of the validation strategy. B, purification of
proteins conjugated to His8-ubiquitin. Strains with the indicated gene
fused to a TAP tag (carboxyl-terminal fusion at the endogenous locus)
that expressed (
) or not () His8-ubiquitin were treated for 30 min
with MG132 (
) or DMSO alone (). For each set of analyses an equal
amount of crude extract protein (8–12 mg) was used for IMAC in
buffer containing 8 M urea plus 0.1% SDS. Eluted material was then
separated by SDS-PAGE on a 7.5% gel followed by immunoblotting
with anti-calmodulin-binding peptide antibody. Only the regions
above the unmodified tagged proteins are shown. * denotes experi-
ments that revealed a weak MG132-dependent enrichment. Note that
only the signal of Met13-TAP was not increased after the addition of
MG132. Ubi, ubiquitin.
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parison of our dataset with a global green fluorescent protein
localization study (39) revealed that UPS substrates were
recovered from all major cellular compartments but were no-
tably de-enriched in mitochondria and peroxisomes (Fig. 3C).
This is not surprising given that there is no known retrotrans-
location pathway for the proteasome-dependent degradation
of mitochondrial and peroxisomal proteins that are seques-
tered from the cytoplasm (note that the few identified mito-
chondrial proteins may have been ubiquitylated prior to their
translocation into the organelle). When we assessed the
abundance of UPS substrates using a previously reported
global analysis of protein expression levels (40), we found that
highly abundant proteins (105 molecules/cell) were enriched
6-fold in the pool of proteasome substrates (Fig. 3D). Al-
though our dataset was slightly biased against proteins pres-
ent at less than 1000 molecules/cell (i.e. 0.7-fold enrichment),
we nevertheless detected some of the least abundant yeast
proteins, including Gcn4, Ecm3, and Cpr4 (estimated to be
present at less than 50 molecules/cell (40)). Taken together,
these data indicate that our approach provided a “broad and
deep” view of the ubiquitylated proteins that are targeted to
the proteasome for degradation regardless of their function,
localization, or abundance.
The Rpn10-dependent Ubiquitin Conjugates—Previous
studies have resulted in the identification of several ubiquity-
lated substrates that depend on the proteasome receptor
Rpn10 for targeting and degradation (5, 15). However, it is
unclear which portion of ubiquitylated proteins is influenced
by Rpn10. Given that rpn10 mutants are viable and have
modest phenotypes, it is possible that Rpn10 contributes to
the degradation of only a small fraction of proteasome sub-
strates. A competing hypothesis is that Rpn10 contributes to
the degradation of a relatively large number of proteasome
substrates, but these substrates can use other receptor path-
ways when Rpn10 is absent. Such substrates might be
missed in a subtractive search for substrates that are found
uniquely in rpn10 but not wild-type cells (15) because this
type of search is biased toward identifying those substrates
that poorly engage an alternative pathway in the absence of
Rpn10. However, a quantitative method that can detect
changes in accumulation of ubiquitylated proteins might re-
veal substrates influenced by RPN10 even if their degradation
is only modestly retarded in the absence of Rpn10 due to their
ability to engage redundant targeting mechanisms.
To address the question of how many ubiquitylated species
exhibit a change in accumulation upon loss of Rpn10, we
compared the ubiquitin conjugate proteomes of wild-type and
rpn10 cells. Cells lacking RPN10 grown in 14N and wild-type
cells grown in 15N were mixed together, lysed, and subjected
to sequential affinity purification of ubiquitin conjugates fol-
lowed by MudPIT and quantitative analysis as described in
Fig. 1. In this analysis, quantitative information was obtained
for 530 proteins (Fig. 4A, middle panel). We identified 122
proteins that were specifically enriched in rpn10 cells (Sup-
plemental Fig. 3A and Table 7). Among these proteins, both
Sic1 and Gcn4, which require RPN10 for turnover at normal
rates (5, 15), were identified. Thus, these proteins serve as
internal standards to lend confidence that this approach can
successfully identify proteins whose degradation is influenced
by RPN10. It is important to note that this does not mean that
these substrates depended, in an absolute sense, upon
Rpn10 for their turnover. Rather in the absence of Rpn10, the
amount of these substrates that accumulated as ubiquitylated
FIG. 3. The UPS proteome. A, frequency distributions of log ratios
in the MG132-treated 15N cell experiment (dark blue) and reference
experiment (light blue; see also Fig. 4A) using the LTQ ion trap.
Truncation of the graph excluded some log ratios with extreme val-
ues. B, pie diagram representing the distribution of proteasome sub-
strate functions (with indicated percentage). Gene ontologies were
retrieved from the Saccharomyces Genome Database (www.stanford.
edu/Saccharomyces). C, histograms representing the percentage of
proteins in the whole (light blue) and UPS (dark blue) proteomes that
are localized in one of four major cellular compartments: cytoplasm
(cytoplasm, bud, bud neck, microtubule, and actin), nucleus (nucleus,
nucleolus, nuclear periphery, spindle pole, and microtubule), mem-
brane-associated organelles (endoplasmic reticulum, Golgi, endo-
some, vacuole, lipid particle, cell periphery, and punctate composite),
and mitochondria plus peroxisomes. Information was retrieved from a
global study based on localization of green fluorescent protein fusion
proteins expressed from endogenous loci (39). Note that some pro-
teins localized in more than one compartment. D, table representing
different categories of protein abundances. Protein abundances were
retrieved from a previous study based on a genome-wide collection of
TAP tagged open reading frames (40), and categories were arbitrarily
established using abundance values (column a). Of the 4102 proteins
that were successfully quantified, the number of proteins in each
category is listed (column b) as is the percentage of total proteins
represented by that category (column c). Of the 225 putative UPS
substrates identified in the MG132 analysis, 169 were quantified by
Ghaemmaghami et al. (40). Of these, the total number that fall into
each abundance category is listed (column d) as is the corresponding
percentage (column e). Column f equals column e divided by column
c and thus represents the degree of enrichment for proteins in each
abundance category. resp., response; mito., mitochondria; pero., per-
oxisomes; assoc., associated.
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species was higher. This can be due to several reasons. The
most likely is that degradation of the ubiquitylated intermedi-
ate was slowed in the absence of Rpn10. However, it is also
possible for some substrates that loss of Rpn10 repressed
editing by deubiquitylating (DUB) enzymes or increased the
rate of ubiquitylation. Regardless of the exact mechanism at
play, the quantification approach used here reveals that
Rpn10 has a broad impact on the UPS.
Quantitative Analysis of the UIM Domain of Rpn10—We
sought to determine whether this approach could also un-
cover UPS substrates whose metabolism was influenced by
the UIM domain of Rpn10. We had previously failed to identify
UIM-dependent targets using a subtractive approach.4 Dele-
tion of UIM yields no known cellular phenotype unless the
uim mutation is combined with other mutations that com-
promise the UPS (5). This scenario is compatible with at least
two hypotheses. On the one hand, the UIM domain of
Rpn10 might only target a small portion of the UPS pro-
teome. Alternatively the UIM domain might not be involved
in substrate degradation unless other targeting mechanisms
are compromised.
To address the role of the UIM domain, we compared the
ubiquitin conjugate proteomes of wild-type and uim cells.
Mutant uim cells grown in 14N and wild-type cells grown in
15N were processed as for the RPN10 analysis (Fig. 4A, right
panel). We found that the distribution of log ratios, when
compared with that obtained in the reference experiment,
exhibited a shift to the right and increased spread but to a
much lesser extent than that seen in the RPN10 and MG132
analyses. We performed a reciprocal experiment to ensure
that this increase was specific to the UIM deletion and found
a very similar result (data not shown). Our results suggest the
existence of specific proteins that accumulate as ubiquitin
conjugates when the UIM domain is mutated. Because the
perturbation was relatively subtle (1  0  15%), low q value
thresholds (e.g. 0.05) were associated with poor recovery
rates (Supplemental Fig. 3A). Hence in this particular case, we
used a less restrictive threshold (0.15) to increase the re-
covery rate (75%). Among the 35 proteins that specifically
accumulated in uim cells (Supplemental Table 8), we se-
lected three candidate genes for validation according to their
availability (CPA1, DSE1, and YBR071W). Using the same
approach as in Fig. 2A, we were able to confirm an increase
of ubiquitin conjugate levels in uim cells for these three
candidates (Fig. 4B; note that both DSE1 and YBR071W have
q values between 0.1 and 0.15). To date, no such protein has
ever been described. This result illustrates the ability of shot-
gun-based isotopic quantification to identify UPS substrates
whose metabolism is influenced by a particular functional
element (i.e. the UIM domain of Rpn10) even when mutation of
that element has little or no discernable phenotype.
Proportional Impact of the Rpn10 Deletion on Proteasome
4 T. Mayor and R. J. Deshaies, unpublished data.
FIG. 4. Analysis of the impact of Rpn10 on the UPS proteome. A,
frequency distributions of log ratios. All analyses were performed
using the LTQ ion trap. The reference experiment (displayed on the
left) was performed by comparing 14N WT versus 15N WT cells (370
proteins). Using the same method applied to the reference experi-
ment in Fig. 1, the variance (2) was estimated at 0.46. In the 14N
rpn10 versus 15N WT analysis, 530 proteins were quantified (middle),
and in the 14N uim versus 15N WT analysis, 344 proteins were
quantified (right). The bell-shaped distribution obtained in the refer-
ence experiment is depicted in the three panels as a dotted line. Only
frequencies for log ratio3 are shown. B, validation of UIM-depend-
ent proteasomal targets. Proteins conjugated to His8-ubiquitin were
purified. Lysates of RPN10 (
) and uim () strains with the indicated
gene fused to a TAP tag (carboxyl-terminal fusion at the endogenous
locus) and that expressed (
) or did not express () His8-ubiquitin
were compared. For each set of samples an equal amount of crude
extract protein (3–6 mg) was used for IMAC in buffer containing 8 M
urea plus 0.1% SDS. Eluted materials were separated by SDS-PAGE
on a 4–20% gel followed by immunoblotting with anti-TAP antibody
(top panel). Total cell extracts were fractionated by SDS-PAGE on a
10% gel followed by immunoblotting with PSTAIRE antibody (bottom
panel). C, analysis of the influence of Rpn10 on the UPS proteome. A
Venn diagram representing the overlaps of the 225 proteasomal sub-
strates, depicted in gray, with total ubiquitylated proteins identified in
the rpn10 (light blue) versus those conjugates that accumulated in
rpn10 cells (dark blue) is shown. D, histogram representing the
percentage of proteins functioning in translation (Transl.) and DNA-
associated proteins (DNA-APs) that were enriched in MG132-treated
cells (LTQ experiment; light blue) or Rpn10 cells (dark blue). The p
values calculated with Fisher’s test were 0.04 and 0.004, respectively.
E, impact of loss of the UIM domain of Rpn10 on the UPS proteome.
Venn diagrams representing the overlaps of the 225 proteasomal
substrates (left) or 122 proteins enriched in rpn10 cells (right) with
proteins identified in the UIM analysis (light blue) and proteins spe-
cifically enriched in uim cells (dark blue) are shown.
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Substrates—To gain a better idea of how broad a contribution
Rpn10 makes to the operation of the UPS, we sought to
determine what fraction of UPS substrates identifiable by our
method (i.e. those conjugates that accumulated upon treat-
ment of cells with MG132) also accumulated upon deletion of
RPN10. The estimated proportion of proteins affected by the
loss of RPN10 (1 0  45%) is lower than in MG132-treated
cells (Fig. 3A; 1  0  75%). This indicates that, on a
proteome-wide level, the loss of RPN10 has less impact on
polyubiquitylated proteins than does inhibition of the protea-
some. This is not surprising given the existence of multiple
receptors that guide ubiquitylated proteins to the proteasome.
To identify the UPS substrates whose degradation is influ-
enced by RPN10, we focused on the 225 proteins enriched in
MG132-treated cells (Supplemental Table 6) and evaluated
their enrichment in the rpn10 analysis. Among the 225 ubiq-
uitylated species that accumulated in MG132-treated cells,
159 were also present in the rpn10 versus WT analysis,
including 43 proteins that were enriched in the mutant cells
(Fig. 4C). This degree of overlap (159/225  70%) is antici-
pated by the observation that any single MudPIT run reveals
2⁄3 of the identifiable proteins in a complex sample (41). This
result suggests that metabolism of 27% (43 of 159) of all UPS
substrates detectable in the two separate analyses was influ-
enced by Rpn10 (Fig. 4C).
To further address whether a particular class of substrates
was specifically affected by Rpn10 absence, we compared
the distributions of the different functional classes. As in the
previously analysis (Fig. 3B), a large array of classes were
represented among the proteins enriched in Rpn10 cells,
suggesting a broad function of Rpn10 in the UPS (Supple-
mental Fig. 3B). However, some variations could be observed
when the two analyses were compared (RPN10 versus
MG132). Notably fewer proteins associated to small molecule
metabolism were identified in rpn10 cells (Supplemental Fig.
3B). Concurrently the proportions of proteins functioning in
translation and DNA-associated proteins were significantly
enhanced (Fig. 4D). This suggests that Rpn10 may be more
important for the degradation of that particular subset of
ubiquitylated proteasome substrates.
Proportional Impact of the UIM Domain—We next per-
formed a comparative analysis, as for the prior analysis of
rpn10, to gauge the influence of the UIM domain of Rpn10
on UPS substrates. In this case, of the 225 putative UPS
substrates found to accumulate in the MG132 experiment,
106 were detected in the uim versus WT analysis. Of these,
only eight were enriched in uim cells, representing 7.5% (8
of 106) of the UPS-pooled substrates (Fig. 4E, left diagram).
This shows that deletion of the UIM domain has far less
impact than deletion of RPN10. Indeed when we considered
the overlap between the RPN10 and UIM analysis, only about
22% of proteins enriched in rpn10 cells were also enriched
in uim cells (11 of 51; Fig. 4E, right diagram). The implication
of this result is that, of the UPS substrates influenced by
Rpn10, only about one-fifth are sensitive to loss of the UIM
domain. This shows that Rpn10 functions on different pools of
proteasome substrates using two distinctive mechanisms.
The dominant function of Rpn10 is provided by the VWA
domain that does not directly bind to ubiquitin, whereas the
UIM domain, which can bind to polyubiquitin chains, targets a
smaller portion of proteasome substrates.
DISCUSSION
We performed quantitative analysis using 15N metabolic
labeling to measure variations in levels of ubiquitin conjugates
after chemical and genetic perturbations. In a first series of
experiments, we were able to specifically identify UPS sub-
strates using the proteasome inhibitor MG132. We then ex-
tended our analysis to identify ubiquitylated proteins that are
affected by the Rpn10 pathway. This enabled the identifica-
tion of several ubiquitylated substrates whose metabolism is
influenced by the UIM domain of Rpn10. Finally we compared
the different analyses to gauge the relative impact of deleting
sequences encoding either the entire RPN10 or only its UIM
domain on the UPS proteome.
The Rpn10 Pathway—By comparing datasets for ubiquitin
conjugates that accumulate when the proteasome is inhibited
with MG132 (putative UPS substrates) and those that accu-
mulate in rpn10 cells, we estimated that Rpn10 influenced
the steady-state level of ubiquitin conjugates for up to 27%
of all UPS substrates (Fig. 5). The simplest interpretation of
this result is that Rpn10 contributes to the turnover of a
significant number of ubiquitylated proteins. However, we
cannot exclude the possibility that in some cases the role of
Rpn10 in turnover is indirect or that the increase in conjugates
is due to increased ubiquitylation or decreased deubiquityla-
tion. Interestingly there were also several proteins that were
significantly de-enriched in rpn10 cells suggesting that
Rpn10 function might be broader than suspected. Given that
rpn10 cells exhibit mild phenotypes (12) this important im-
pact of rpn10 in our experiments is somewhat surprising.
Presumably the “Rpn10-dependent” candidate substrates re-
ported here do not rely exclusively on Rpn10 for delivery to
the proteasome. Instead it is more likely that substrates that
FIG. 5. Proteasome substrates using Rpn10 pathway. Schematic
representation of the “flux” of UPS substrates using the indicated
pathways. Estimates of total proteasome substrate fractions are de-
picted in black, whereas Rpn10 target distributions influenced by the
UIM or VWA domains are shown in gray.
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use Rpn10 can also use other receptor pathways, albeit with
reduced overall efficiency, when Rpn10 is absent as is the
case for Sic1 (5).
The role of the UIM domain of Rpn10 in the UPS has been
perplexing. Although it was the first polyubiquitin binding
domain to be identified, it remained unclear whether it plays
any role in proteolysis in wild-type cells. The Rpn10-depend-
ent substrates Sic1 and Gcn4 are unaffected by the UIM
deletion unless it is combined with deletions of other recep-
tors such as RAD23 (5).2 In this analysis we identified several
ubiquitylated substrates that accumulated in uim cells (Sup-
plemental Table 8). To our knowledge, these represent the
first physiological UPS substrates that have been shown to be
affected by loss of the UIM domain by itself. This shows that
there is a dual role for Rpn10 function at the proteome-wide
level (Fig. 5). Those identified proteins can now be used as
“indicator proteins” to unravel the physiological role of the
UIM domain. The notion of using mass spectrometry to iden-
tify an “indicator protein” should be readily applicable to other
poorly understood components of the UPS.
Of the proteins accumulating as ubiquitylated species upon
RPN10 deletion, only one-fifth accumulated upon the selec-
tive deletion of the UIM domain. This is consistent with the
observation that rpn10 cells have a more severe growth
defect than uim cells (12). The substrates that accumulated
in rpn10 but not uim cells presumably are dependent upon
the VWA domain. The VWA domain enhances the degradation
of ubiquitylated Sic1 docked to the proteasome by the Rad23
receptor, but the biochemical function of the VWA domain
remains unknown. Interestingly ribosome and DNA-associ-
ated proteins were found to be significantly enriched in the
Rpn10 analysis but not in the UIM analysis (data not shown).
These proteins are part of large and tight complexes. It is
possible that the VWA might participate in the structural con-
formation of the 19 S subunit of the proteasome, favoring a
larger entry site for the substrate or better alignment with
other proteasomal functions (e.g. Rpn11-DUB or the chaper-
one activities of Rpt).
The UPS Proteome—Our analysis revealed a large number
of ubiquitylated proteins that accumulated upon inhibition of
the proteasome, including relatively low abundance cell cycle
control proteins whose activity is known to be regulated by
proteolysis (G1 cyclins Cln1, Cln2, and Pcl1; B-type cyclin
Clb2; and Cdk inhibitors Sic1 and Far1). Interestingly we also
found and confirmed that abundant, presumably stable pro-
teins (ribosomal protein Rps8A, enolase, and phosphoglycer-
ate kinase) accumulated as ubiquitylated species upon inhi-
bition of the proteasome with MG132 (Fig. 2B). It is possible
that these proteins succumbed to quality control mechanisms
that eliminate improperly translated, misfolded, or damaged
proteins (42, 43). If so, the methods reported here may be
useful for studying on a proteome-wide scale the chaperones
involved in protein folding and assembly. An important feature
of our method is that we use consecutive affinity purification
steps to focus our analysis on proteasome substrates and
bias against contaminating proteins. The effectiveness of this
strategy is underscored by the fact that 22% of our candi-
date UPS substrates are present at 1000 molecules/cell,
whereas only 6.8% of proteins identified in a single MudPIT
analysis of crude extract are of equivalent abundance (41).
The positive attributes of this method suggest that it should
be generally useful for identifying targets of specific ubiquitin
ligases and deubiquitylating enzymes.
General Issues in Quantitative Profiling of UPS Substrates—
The accumulation of a particular substrate in any given ex-
periment was likely guided by several factors, including the
amount of co-accumulating substrates, the relative activity of
individual ubiquitin ligases and DUB enzymes that act upon
the substrate, the relative ability of different ubiquitylation
pathways to incorporate His6-ubiquitin or compete for free
ubiquitin, and the degradation rate of the ubiquitylated pro-
tein. Because of these factors, we believe there is little value
in investing great significance in individual ratios when draw-
ing conclusions in a proteomics manner. Thus, we limited our
analysis to classifying proteins as being enriched or not.
In many cases the enrichment values for UPS substrates
were lower than the threshold of 4 (or 2 when expressed in
log2 scale) often applied in microarray analyses of mRNA
expression (44). In our experiments, the total enrichment for
ubiquitin recovered from MG132-treated compared with un-
treated cells averaged only 1.9-fold (in Fig. 1). Thus, one
would expect the average ubiquitylated substrate to accumu-
late 2–3-fold. This value agrees with immunoblot analysis of
ubiquitin conjugates in total cell extracts. Although we could
have increased this value by longer treatment with MG132,
excessive accumulation of conjugates runs the risk of deplet-
ing cellular ubiquitin, thereby causing its redistribution to dif-
ferent proteins (45, 46). Remarkably despite the limited extent
of accumulation of total ubiquitin conjugates, large variations
in accumulation of specific conjugates were seen.
We used a statistical analysis based on q values to identify
proteins for which the ubiquitylation level was altered. The
reference experiment, in which two biologically equivalent
pools were compared, provided crucial information regarding
the typical variation arising from simple biological variability
and experimental noise. Protein-specific p values provide a
statistical measure of the inconsistency between the ob-
served log ratio and a null hypothesis of no enrichment or
depletion. We further modified our p values prior to forming
lists to address the perennial problem in “omic” analyses,
namely the large scale multiple testing problem. A simple filter
for p values only allows a selection based on the error rate
(proportion of unaffected ORFs that are considered enriched,
i.e. false negative), whereas q values allow the setting of a
threshold FDR (based on false positive rate). By setting a q
value threshold of 0.05 (or 0.15 in the UIM analysis), the lists
of putative proteome substrates have, on average, a false
positive proportion smaller than 5% (or 15%). Note that in all
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experiments the error rates were below or close to 10%. In
addition to the absolute meaning of the q value cutoff in terms
of the FDR, our choice of cutoff was guided by a desire to
recover a high proportion (which we estimated to be close to
80% in most of our analyses) of the ORFs that responded to
a chemical (MG132) or genetic (rpn10, uim) perturbation of
the UPS. Manual validation of a subset of proteins from the
MG132 and uim analyses confirmed the efficacy of the ap-
proach. To our best knowledge, this is the first analysis that
combines the null distribution of a reference experiment and q
value test to identify responsive or affected proteins in quan-
titative mass spectrometry analysis. This method offers con-
siderable promise that could be broadly applied to other
proteomics studies.
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